Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
U.S. patent for breast cancer detection through biomarkers granted
July 28th, 2005
Power3 Medical Products, Inc., (PWRM.PK) announced that the U.S. Patent and Trademark Office has issued Patent No. 6,855,554, for which the company has a nonexclusive license from The University of Texas M. D. Anderson Cancer Center. This patent covers the method of discovering and detecting breast cancer through the identification of protein markers or a pattern of protein markers obtained from the application of proteomics to breast nipple aspirate fluid from women being tested for breast cancer. A second patent application, filed jointly by M. D. Anderson and the company, covering the proteomic techniques used in the company's NAFTest, is the...
Source: Women's Health Weekly (2005-07-28)
|
